|
(Health-NewsWire.Net, September 22, 2015 ) Portland, OR --
About Stem Cell UCB
UCB is the blood that remains in the placenta and the attached umbilical cord after childbirth. UCB contains stem cells that are unique, smart, and are capable of treating several life-threatening diseases. They are used in the treatment of hematopoietic and genetic disorders. The placental blood can produce 10 times more quantity of stem cells compared to the umbilical cord, which can in turn be used for the treatment of an adult patient. The cord blood that is collected during the childbirth is stored and cryopreserved. The storage of the cord blood can be done at private cord blood banks or public cord blood banks. This preserved blood can be used for the transplantation, and treatment of diseases at the later stages of life.
The global Stem Cell UCB market to grow at a CAGR of 30.36% over the period 2014-2019.
Enquire about this report at: http://www.bigmarketresearch.com/report-enquiry/280090
Covered in this Report
The report covers the present scenario and the growth prospects of the global stem cell UCB market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the banking and utilization of UCB stem cells for the treatment of various disorders, such as cancers, blood disorders, metabolic disorders, immune diseases, and others.
Global Stem Cell UCB Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global stem cell UCB market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key Regions
• Americas
• APAC
• EMEA
Key Vendors
• Caladrius Biosciences
• Celgene
• Mesoblast
• Pluristem Therapeutics
Other Prominent Vendors
• Athersys
• CHA Bio and Diostech
• Cytori Therapeutics
• Nuo Therapeutics
• Ocata Therapeutics
• Opexa Therapeutics
• Osiris Therapeutics
• Teva Pharmaceuticals
• United Therapeutics
Key Market Driver
• Effective Treatment of Life-threatening Diseases
• For a full, detailed list, view our report
Key Market Challenge
• Stringent Regulations
• For a full, detailed list, view our report
Key Market Trend
• Growing Public Awareness
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
Contact Details:
James Jordan
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
Email: help@bigmarketresearch.com
Web: http://www.bigmarketresearch.com
Big Market Research
James Jordan
+ 1-503-894-6022
james@bigmarketresearch.com
Source: EmailWire.Com 
|
